£41.40

This is the most expensive it has ever been. Walk away.

£41 today · previous high £41 · all-time low £40

Humana Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 74 days · 74 data points (no recent data)

Historical
Generating forecast…
£41.40 £39.81 £40.15 £40.50 £40.85 £41.20 £41.55 11 August 2026 29 August 2026 16 September 2026 04 October 2026 23 October 2026
View at Amazon ↗

9781588297518

Price data last checked 17 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 74 days • 2 price levels

Days at Price
Current Price
57 days 17 days · current 0 14 29 43 57 £40 £41 Days at Price

Price Analysis

Most common price: £40 (57 days, 77.0%)

Price range: £40 - £41

Price levels: 2 different prices over 74 days

Description

Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and others are in the late phases of clinical development. Likewise, surgical and ablative options, as well as an array of supportive medications, have shown substantial progress and undergone a dramatic proliferation over the past decade. With the increased number of therapeutic options from which to choose, the clinician is better able to offer effective therapy to the patient with colorectal cancer. The clinician is challenged, however, to keep up with the rapidly changing landscape and the rapidly emerging data that shape the options for treatment today and tom- row. In this text, leaders in the management of colorectal cancer review the current literature that has led us to where we are today. Critical evaluations of the data are offered, and evidence-based recommendations are made.

Key Features

Used Book in Good Condition

Product Specifications

Brand
Humana
Format
hardcover
Domain
Amazon UK
Release Date
01 September 2006
Listed Since
13 February 2007

Barcode

No barcode data available

Similar Products You Might Like

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)
96% match

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Humana

£80.67 24 Oct 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
86% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.65 22 Oct 2026
Colorectal Cancer Screening (Clinical Gastroenterology)
85% match

Colorectal Cancer Screening (Clinical Gastroenterology)

Humana

£80.67 02 Nov 2026
Colon Cancer Diagnosis and Therapy: Volume 2
85% match

Colon Cancer Diagnosis and Therapy: Volume 2

Springer

£121.64 26 Oct 2026
Molecular Pathogenesis of Colorectal Cancer
84% match

Molecular Pathogenesis of Colorectal Cancer

Springer

£112.57 23 Oct 2026
Management of Colorectal Cancers in Older People
84% match

Management of Colorectal Cancers in Older People

Springer

£80.67 21 Oct 2026
Patient Surveillance After Cancer Treatment (Current Clinical Oncology)
83% match

Patient Surveillance After Cancer Treatment (Current Clinical Oncology)

Humana

£141.67 02 Nov 2026
Multidisciplinary Management of Rectal Cancer: Questions and Answers
82% match

Multidisciplinary Management of Rectal Cancer: Questions and Answers

Springer

£102.12 23 Oct 2026
Hereditary Colorectal Cancer: Genetic Basis and Clinical Implications
82% match

Hereditary Colorectal Cancer: Genetic Basis and Clinical Implications

Springer

£141.67 23 Oct 2026
Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)
81% match

Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)

Springer

£109.35 23 Oct 2026
Management of Pancreatic Cancer and Cholangiocarcinoma
81% match

Management of Pancreatic Cancer and Cholangiocarcinoma

Springer

£105.60 04 Nov 2026
Complexities in Colorectal Surgery: Decision-Making and Management
81% match

Complexities in Colorectal Surgery: Decision-Making and Management

Springer

£89.28 23 Oct 2026
Colorectal Cancer: Prevention, Diagnosis and Treatment
81% match

Colorectal Cancer: Prevention, Diagnosis and Treatment

£58.64 22 Oct 2026
Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)
80% match

Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)

Humana

£113.76 24 Oct 2026
Causes and Control of Colorectal Cancer: A Model for Cancer Prevention: 78 (Developments in Oncology, 78)
80% match

Causes and Control of Colorectal Cancer: A Model for Cancer Prevention: 78 (Developments in Oncology, 78)

Springer

£148.31 23 Oct 2026
Cancer Gene Therapy (Contemporary Cancer Research)
80% match

Cancer Gene Therapy (Contemporary Cancer Research)

Humana

£166.07 24 Oct 2026
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)
80% match

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Humana

£76.42 23 Oct 2026
Active Surveillance for Localized Prostate Cancer: A New Paradigm for Clinical Management (Current Clinical Urology)
80% match

Active Surveillance for Localized Prostate Cancer: A New Paradigm for Clinical Management (Current Clinical Urology)

Humana

£88.21 27 Oct 2026
Molecular Genetics of Colorectal Neoplasia: A Primer for the Clinician: 82 (Developments in Oncology)
80% match

Molecular Genetics of Colorectal Neoplasia: A Primer for the Clinician: 82 (Developments in Oncology)

Springer

£84.76 23 Oct 2026
Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (Cancer Drug Discovery and Development)
80% match

Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins (Cancer Drug Discovery and Development)

Humana

£77.77 24 Oct 2026
Genetics of Colorectal Cancer (Cancer Genetics)
79% match

Genetics of Colorectal Cancer (Cancer Genetics)

Springer

£113.93 23 Oct 2026
Bladder Cancer: Diagnosis, Therapeutics, and Management (Current Clinical Urology)
79% match

Bladder Cancer: Diagnosis, Therapeutics, and Management (Current Clinical Urology)

Humana

£80.65 22 Oct 2026
Chemokines and Cancer (Contemporary Cancer Research)
79% match

Chemokines and Cancer (Contemporary Cancer Research)

Humana

£128.14 24 Oct 2026
Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)
79% match

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£144.51 23 Oct 2026